| COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... Journal of the American college of cardiology 75 (23), 2950-2973, 2020 | 3380 | 2020 |
| Edoxaban for the treatment of cancer-associated venous thromboembolism GE Raskob, N Van Es, P Verhamme, M Carrier, M Di Nisio, D Garcia, ... New England Journal of Medicine 378 (7), 615-624, 2018 | 1650 | 2018 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1043 | 2021 |
| Apixaban to prevent venous thromboembolism in patients with cancer M Carrier, K Abou-Nassar, R Mallick, V Tagalakis, S Shivakumar, ... New England Journal of Medicine 380 (8), 711-719, 2019 | 815 | 2019 |
| Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report LK Moores, T Tritschler, S Brosnahan, M Carrier, JF Collen, K Doerschug, ... Chest 158 (3), 1143-1163, 2020 | 702 | 2020 |
| Restrictive or liberal red-cell transfusion for cardiac surgery CD Mazer, RP Whitlock, DA Fergusson, J Hall, E Belley-Cote, K Connolly, ... New England Journal of Medicine 377 (22), 2133-2144, 2017 | 691 | 2017 |
| American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer GH Lyman, M Carrier, C Ay, M Di Nisio, LK Hicks, AA Khorana, AD Leavitt, ... Blood advances 5 (4), 927-974, 2021 | 628 | 2021 |
| Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism M Carrier, G Le Gal, PS Wells, MA Rodger Annals of internal medicine 152 (9), 578-589, 2010 | 545 | 2010 |
| Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta‐analysis of the management outcome studies M Carrier, M Righini, PS Wells, A Perrier, DR Anderson, MA Rodger, ... Journal of Thrombosis and Haemostasis 8 (8), 1716-1722, 2010 | 487 | 2010 |
| Role of direct oral anticoagulants in the treatment of cancer‐associated venous thromboembolism: guidance from the SSC of the ISTH AA Khorana, S Noble, AYY Lee, G Soff, G Meyer, C O'Connell, M Carrier Journal of thrombosis and haemostasis 16 (9), 1891-1894, 2018 | 443 | 2018 |
| Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? M Carrier, G Le Gal, PS Wells, D Fergusson, T Ramsay, MA Rodger Annals of internal medicine 149 (5), 323-333, 2008 | 411 | 2008 |
| Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or … B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... J Am Coll Cardiol 75 (23), 2950-2973, 2020 | 405 | 2020 |
| Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty DR Anderson, M Dunbar, J Murnaghan, SR Kahn, P Gross, M Forsythe, ... New England journal of medicine 378 (8), 699-707, 2018 | 393 | 2018 |
| Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant JD Douketis, AC Spyropoulos, J Duncan, M Carrier, G Le Gal, AJ Tafur, ... JAMA internal medicine 179 (11), 1469-1478, 2019 | 378 | 2019 |
| The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies MA Rodger, MT Betancourt, P Clark, PG Lindqvist, D Dizon-Townson, ... Plos medicine 7 (6), e1000292, 2010 | 375 | 2010 |
| Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology GC Nguyen, CN Bernstein, A Bitton, AK Chan, AM Griffiths, GI Leontiadis, ... Gastroenterology 146 (3), 835-848. e6, 2014 | 361 | 2014 |
| Screening for occult cancer in unprovoked venous thromboembolism M Carrier, A Lazo-Langner, S Shivakumar, V Tagalakis, R Zarychanski, ... New England Journal of Medicine 373 (8), 697-704, 2015 | 337 | 2015 |
| Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 … M Sholzberg, GH Tang, H Rahhal, M AlHamzah, LB Kreuziger, FN Áinle, ... bmj 375, 2021 | 329 | 2021 |
| Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): a systematic review and meta-analysis A Li, DA Garcia, GH Lyman, M Carrier Thrombosis research 173, 158-163, 2019 | 304 | 2019 |
| VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism M Carrier, M Righini, RK Djurabi, MV Huisman, A Perrier, PS Wells, ... Thrombosis and haemostasis 101 (05), 886-892, 2009 | 295 | 2009 |
